Dr. Graham Mazereeuw

Biography

Medical School :

University of Toronto, 2019

Residency:

University of Toronto Family Medicine, 2021

University of Ottawa Emergency Medicine, 2022

Personal Interests/Personal philosophy or quote:

• Being outdoors
• Premier league soccer
• Dad jokes

Publications:

1. Mazereeuw G, Gomes T, Macdonald EM, Greaves S, Li P, Mamdani MM, Redelmeier DA, Juurlink DN, 2020. Oxycodone, hydromorphone and the risk of suicide: a retrospective population-based case-control study. Drug Safety 43(8): 737-43; 2. Mazereeuw G, Sullivan MD, Juurlink DN, 2018. Depression in chronic pain: might opioids be responsible? PAIN 159(11): 2142-2145; 3. Cressman AM, Mazereeuw G, Guan Q, Xia W, Gomes T, Juurlink DN, 2017. Availability of naloxone in Canadian pharmacies. Canadian Medical Association Journal – Open 5(4): E779-84; 4. Mazereeuw G, Herrmann N, Oh PI, Ma DWL, Wang CT, Kiss A, Lanctôt KL, 2016. Omega-3 fatty acids, depressive symptoms, and cognitive performance in coronary artery disease patients: analyses from a randomized, double-blind, placebo-controlled trial. Journal of Clinical Psychopharmacology 36(5): 436-44